rip prof rebello faculty jbims, isb | scope of mba & hr after covid | my last interview with sir
Published 3 years ago • 11K plays • Length 17:05Download video MP4
Download video MP3
Similar videos
-
3:59
david d’ambrosio, md, radiation oncologist & director of cyberknife at community medical center
-
11:45
prof. sir michael marmot: bjgp webinar on health inequalities
-
1:39
treating patients with myelofibrosis who are intolerant to or develop resistance to jak inhibitors
-
4:28
dr jamie brennan
-
1:50
faces of diabetes innovation: charles brenner, ph.d.
-
40:32
ijgc journal club april 2024
-
51:52
close the health gap | michael marmot
-
12:38
healthcare: humanity above bureaucracy | jos de blok | tedxgeneva
-
0:58
dr. julie r. brahmer on immunotherapy development in lung cancer
-
9:42
fred levine, m.d., ph.d. - a new approach to restore insulin production in diabetes
-
17:12
hyperbaric oxygen therapy indications and patient selection john j brummer
-
7:09
jamie's story - #bthevoice taiwan
-
1:12:31
viruses from scratch - 2010 buhl lecture
-
2:52
ims-mrl research paper summary - josca schoonejans, former phd student
-
17:42
aspects of covid-19 immunity
-
6:55
interview with dr. jacquie ripat and jonathon lyon - 680 cjob
-
1:07:04
reporting guidelines for health research
-
12:20
respiratory virus research at the interface with policy | professor jonathan van-tam fmedsci
-
9:30
investigating the implications of covid-19 on ibd
-
2:09
approved & emerging jak inhibitors for patients with high-risk mf who are transplant-ineligible
-
1:53
ruxolitinib and jak inhibitors prior to transplantation
-
3:01
going beyond the biomarkers by john (jack) c. o'horo, md, mph | preview